Acumen Pharmaceuticals, Inc. promotes presence as Silver Sponsor at Alzheimer association conference in London

Traders Union
All News
Companies
Acumen backs Alzheimer event in London

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Market Voices

Companies

Olga Shendetskaya

12.07.2026

Acumen Pharmaceuticals, Inc. promotes presence as Silver Sponsor at Alzheimer association conference in London — Acumen backs Alzheimer event in London

Acumen Pharmaceuticals, Inc. announced its participation as a Silver Sponsor at the Alzheimer Association International Conference in London.

The company is inviting conference attendees to visit booth 719 to learn more about its latest presentations and research. Acumen Pharmaceuticals, Inc. emphasized its commitment to advancing Alzheimer research and connecting with the scientific community at #AAIC26. Further details are available through the link provided in the announcement.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Acumen Pharmaceuticals recently renewed its focus on developing targeted therapies for Alzheimer patients and their families, according to a previous announcement. The company and JCR Pharmaceuticals also nominated two Enhanced Brain Delivery candidates for Alzheimer research in an earlier update. Both initiatives form part of Acumen’s ongoing research efforts in the Alzheimer's field.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Crypto test drive: How automakers are exploring digital assets

By Anastasiia Chabaniuk
13 hours ago

Crypto test drive: How automakers are exploring digital assets

Editors' Picks

Lindsey Graham death: U.S. senator’s crypto legacy

By Mikhail Vnuchkov
Yesterday

Lindsey Graham death: U.S. senator’s crypto legacy

Editors' Picks

Tether under pressure: USDT in Europe, audit questions, and the fight for trust

By Pavlo Kot
12.07.2026

Tether under pressure: USDT in Europe, audit questions, and the fight for trust

Editors' Picks

All Editors' Top Picks

Latest Acumen News

Acumen Pharmaceuticals, Inc. commits to advancing targeted therapies for Alzheimer care

By Olga Shendetskaya
30.06.2026

Acumen Pharmaceuticals, Inc. commits to advancing targeted therapies for Alzheimer care

Companies

Acumen Pharmaceuticals, Inc. advances two new Enhanced Brain Delivery candidates for Alzheimer treatment

By Parshwa Turakhiya
16.06.2026

Acumen Pharmaceuticals, Inc. advances two new Enhanced Brain Delivery candidates for Alzheimer treatment

Companies

Acumen Pharmaceuticals, Inc. pushes research for brain health as dementia numbers climb

By Eugene Komchuk
02.06.2026

Acumen Pharmaceuticals, Inc. pushes research for brain health as dementia numbers climb

Companies

All Acumen News

Anastasiia Chabaniuk
13 hours ago

Crypto test drive: How automakers are exploring digital assets

Mikhail Vnuchkov
Yesterday

Lindsey Graham death: U.S. senator’s crypto legacy

Pavlo Kot
12.07.2026

Tether under pressure: USDT in Europe, audit questions, and the fight for trust

Pavlo Kot
11.07.2026

Lean Ethereum: Why Buterin wants to rebuild the network

Mikhail Vnuchkov
10.07.2026

SK Hynix debuts on Nasdaq: Largest U.S. offering by foreign company

Hlib Chabaniuk
13 min ago

Ran Neuner: STRC questioned on potential to return to $100 price level

Igor Krasulya
28 min ago

Larry Kudlow: Kevin Warsh delivers first Congressional monetary report as consumer prices drop

Daria Chernytska
28 min ago

Laura Shin: Strongest crypto wallet is not enough if phone is vulnerable

Dmytro Kharkov
1 hour ago

Current market trends reveal emerging opportunities, Rebecca Walser analyzes

Parshwa Turakhiya
1 hour ago

Disinflation in core CPI opens door for rate cuts, Daniel Lacalle notes

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Eugene Komchuk
7 hours ago

ECB selects 36 participants for digital euro pilot

ECB selects 36 participants for digital euro pilot

Olga Shendetskaya
9 hours ago

IBM shares drop after earnings warning

IBM shares drop after earnings warning

Olga Shendetskaya
11 hours ago

U.S. stock futures show mixed moves as oil shock puts CPI in focus

U.S. stock futures show mixed moves as oil shock puts CPI in focus

Hanna Syniavska
12 hours ago

China trade surplus fuels new concerns in Europe

China trade surplus fuels new concerns in Europe

Andrey Mastykin
13 hours ago

Nvidia tightens Asia AI chip sales under U.S. pressure

Nvidia tightens Asia AI chip sales under U.S. pressure

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Apple holds near record highs as AI optimism offsets technical resistance

Mykhailo Ihnatenko
Now

Moderna braces for earnings and FDA catalyst

Mykhailo Ihnatenko
Now

IBM shares tumble after weak preliminary Q2 results

Mykhailo Ihnatenko
Now

Tesla stock in focus as CPI and earnings season begin

Anton Kharitonov
Now

Bitcoin stabilizes as geopolitical risks offset improving institutional demand

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.